We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0SZI market cap is 0. The company's latest EPS is USD -10.1527 and P/E is -3.88.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4.82M | 36.14M | 3.94M | 882k | 0 |
Operating Income | -56.75M | -77.1M | -122.81M | -55.99M | -39.84M |
Net Income | -55.67M | -71.45M | -111.27M | -45.64M | -42.35M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 46.99M | 49.14M | 102.3M | 107.73M | 66.31M |
Total Liabilities | 19.47M | 42.98M | 57.02M | 38.62M | 33.32M |
Total Equity | 27.52M | 6.16M | 45.28M | 69.11M | 32.99M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -30.07M | -45.72M | -99.69M | -48.18M | -37.54M |
Investing | -2.3M | -2.74M | -485k | -73.42M | 30.07M |
Financing | 11.42M | 38.47M | 154.88M | 60.82M | -534k |
Market Cap | 0 |
Price to Earnings Ratio | -3.88 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.67 |
Price to Book Ratio | 4.98 |
Dividend Yield | - |
Shares Outstanding | 4.17M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Corbus Pharmaceuticals Holdings Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.corbuspharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions